Segall Bryant & Hamill’s Imperva, Inc. IMPV Stock Holding History

Segall Bryant & Hamill’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,102	Closed	-$729K	–	893
2018 Q2	$729K	Sell	15,102 -95,050	-86%	-$4.55M	0.01%	597
2018 Q1	$4.77M	Buy	+110,152	New	+$4.95M	0.11%	204

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Segall Bryant & Hamill's IMPV Position: Q3 2018 in Review

Segall Bryant & Hamill sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 15,102 shares — an estimated $729K sold.

Segall Bryant & Hamill first reported a position in IMPV in Q1 2018 and held it in 2 quarters. The position peaked at $4.77M in Q1 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

Segall Bryant & Hamill reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
Segall Bryant & Hamill sold 15,102 Imperva, Inc. shares in Q3 2018, an estimated $729K.
Segall Bryant & Hamill first reported a position in Imperva, Inc. in Q1 2018 and held it in 2 quarters.
Segall Bryant & Hamill's Imperva, Inc. position peaked at $4.77M in Q1 2018.
168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Segall Bryant & Hamill's 13F filing for Q3 2018, filed 14 Nov 2018.